Cargando…
Desmopressin Lyophilisate for the Treatment of Central Diabetes Insipidus: First Experience in Very Young Infants
INTRODUCTION: In neonates and small infants, early diagnosis of central diabetes insipidus (CDI) and treatment with desmopressin in low doses (avoiding severe hypo- or hypernatremia) are important to prevent associated high morbidity and mortality in this particular age group. CASE PRESENTATION: We...
Autores principales: | De Waele, Kathleen, Cools, Martine, De Guchtenaere, Ann, Van de Walle, Johan, Raes, Ann, Van Aken, Sara, De Coen, Kris, Vanhaesebrouck, Piet, De Schepper, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338649/ https://www.ncbi.nlm.nih.gov/pubmed/25745483 http://dx.doi.org/10.5812/ijem.16120 |
Ejemplares similares
-
Population Pharmacokinetic Modeling of a Desmopressin Oral Lyophilisate in Growing Piglets as a Model for the Pediatric Population
por: Gasthuys, Elke, et al.
Publicado: (2018) -
SUN-410 Central Diabetes Insipidus Refractory to Oral Desmopressin (DDAVP)
por: Burdea, Liliana, et al.
Publicado: (2019) -
Ifosfamide-induced nephrogenic diabetes insipidus responsive to supraphysiologic doses of intravenous desmopressin
por: Sohail, Mohammad A., et al.
Publicado: (2021) -
Optimizing response to desmopressin in patients with monosymptomatic nocturnal enuresis
por: Kamperis, Konstantinos, et al.
Publicado: (2016) -
Is vitamin D deficiency in obese youth a risk factor for less weight loss during a weight loss program?
por: Van De Maele, Karolien, et al.
Publicado: (2019)